Drug Reference
Asciminib
BCR-ABL tyrosine kinase inhibitors
Fact box
- Therapeutic class
- BCR-ABL tyrosine kinase inhibitors
- Habit forming
- No
Brand names
Scemblix
Available as
20 MG · Oral Tablet40 MG · Oral Tablet100 MG · Oral Tablet
No structured FDA label was available. Use the authoritative links below.
Current FDA labels (DailyMed)
Authoritative sources
Reference only — not clinical advice. Verify against current FDA labeling and consult a licensed provider. About half of pediatric drug use is off-label and is not reflected in FDA labels; absence of pediatric information does not mean a medicine is unused or unsafe in children.